Funding Opportunities

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
  (PA-18-586)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Strategic Coordination (Common Fund)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Due dates vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
  (PA-18-589)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  John E. Fogarty International Center
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Strategic Coordination (Common Fund)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance.
• Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
  (PA-18-590)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Strategic Coordination (Common Fund)
  National Institute on Minority Health and Health Disparities
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
  (PA-18-591)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Strategic Coordination (Common Fund)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Due dates may vary by awarding IC. See the awarding IC web site for any applicable Application Due Dates.
• Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )
  (PA-18-592)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Strategic Coordination (Common Fund)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Due dates may vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details.
• Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)
  (PAR-18-585)
  National Institute on Aging
  Application Receipt Date(s): March 27, 2018; February 20, 2019; and February 20, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional)
  (PAR-18-587)
  National Institute on Aging
  Application Receipt Date(s): April 10, 2018, January 8, 2019, and January 8, 2020, by 5:00 PM local time of applicant organization.
• Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional)
  (PAR-18-588)
  National Institute on Aging
  Application Receipt Date(s): April 10, 2018, January 8, 2019, and January 8, 2020, by 5:00 PM local time of applicant organization.
• NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
  (PAR-18-594)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): March 27, 2018; July 2, 2018; November 2, 2018; March 4, 2019; July 2, 2019; November 4, 2019; March 3, 2020, July 2, 2020, November 3, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
  (PAR-18-595)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): March 27, 2018, July 2, 2018; November 2, 2018, March 4, 2019, July 2, 2019; November 4, 2019 March 3, 2020, July 2, 2020, November 3, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed)
  (RFA-AG-19-001)
  National Institute on Aging
  Application Receipt Date(s): June 4, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed)
  (RFA-RM-18-001)
  Office of Strategic Coordination (Common Fund)
  National Institute of Mental Health
  Application Receipt Date(s): After acceptance of the corresponding required Letter of Intent (LOI) applications are due April 16, 2018), by 5:00 PM local time of applicant organization.
• Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)
  (RFA-RM-18-012)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 3, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)
  (RFA-RM-18-013)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)
  (RFA-RM-18-015)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-RM-18-016)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed)
  (RFA-RM-18-017)
  Office of Strategic Coordination (Common Fund)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-18-018)
  Office of Strategic Coordination (Common Fund)
  National Human Genome Research Institute
  Application Receipt Date(s): April 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.